HomeRCUS • NYSE
add
Arcus Biosciences Inc
Previous close
$21.97
Day range
$22.32 - $23.04
Year range
$6.50 - $26.40
Market cap
2.81B USD
Avg Volume
1.18M
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 33.00M | 26.92% |
Operating expense | 26.00M | -7.14% |
Net income | -106.00M | -12.77% |
Net profit margin | -321.21 | 11.16% |
Earnings per share | -0.89 | 13.59% |
EBITDA | -111.00M | -11.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 981.00M | 0.31% |
Total assets | 1.14B | -0.96% |
Total liabilities | 508.00M | -23.61% |
Total equity | 631.00M | — |
Shares outstanding | 125.35M | — |
Price to book | 4.36 | — |
Return on assets | -26.98% | — |
Return on capital | -40.20% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -106.00M | -12.77% |
Cash from operations | -120.00M | -20.00% |
Cash from investing | -182.00M | -456.86% |
Cash from financing | 286.00M | 14,400.00% |
Net change in cash | -16.00M | 68.63% |
Free cash flow | -59.50M | -62.46% |
About
Founded
2015
Website
Employees
601
